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Heterotropic association of tissue transglutaminase (TG2)
with extracellular matrix-associated fibronectin (FN) can
restore the adhesion of fibroblasts when the integrin-mediated
direct binding to FN is impaired using RGD-containing peptide.
We demonstrate that the compensatory effect of the TG-FN
complex in the presence of RGD-containing peptides is medi-
ated by TG2 binding to the heparan sulfate chains of the synde-
can-4 cell surface receptor. This binding mediates activation of
protein kinase C (PKC) and its subsequent interaction with
1 integrin since disruption of PKC binding to 1 integrins
with a cell-permeant competitive peptide inhibits cell adhesion
and the associated actin stress fiber formation. Cell signaling by
this process leads to the activation of focal adhesion kinase
and ERK1/2 mitogen-activated protein kinases. Fibroblasts
deficient in Raf-1 do not respond fully to the TG-FN complex
unless either the full-length kinase competent Raf-1 or the
kinase-inactive domain of Raf-1 is reintroduced, indicating
the involvement of the Raf-1 protein in the signaling mecha-
nism. We propose a model for a novel RGD-independent cell
adhesion process that could be important during tissue injury
and/or remodeling whereby TG-FN binding to syndecan-4
activates PKC leading to its association with 1 integrin,
reinforcement of actin-stress fiber organization, and MAPK
pathway activation.
Tissue transglutaminase (TG2)2 belongs to a family of
enzymes that in the presence of Ca2 catalyze the post-trans-
lational modification of proteins either by covalent cross-link-
ing or through the incorporation of primary amines. TG2 has a
GTP binding/hydrolysis site that negatively modulates the
Ca2-dependent transamidating activity of the enzyme by
obstructing access to the active site (1). As a consequence, the
enzyme is likely to be inactive under normal Ca2 homeostasis.
TG2 localizes mainly in the cytoplasm, yet recent reports also
suggest its presence in the nucleus, mitochondria, at the cell
surface, and in the extracellular matrix (ECM) (1–3). TG2 is
translocated to the plasma membrane and was subsequently
deposited into the ECM via a non-classical secretory mecha-
nism reportedly dependent on active site conformation and on
an intact N-terminal -sandwich domain (4, 5) as well as on its
possible association with integrins (6). Deposition of the
enzyme into the ECM after cell damage and stress is important
in the remodeling and/or stabilization of the several ECM pro-
teins, such as FN (7, 8). FN is particularly interesting since TG2
binds to this ECM protein with high affinity promoting wide-
ranging effects on cell-matrix interactions, including the regu-
lation of cell adhesion and migration, matrix assembly, and
adhesion-dependent signaling (6, 7, 9).
Cell adhesion to FN involves a series of coordinated signaling
events orchestrated by numerous transmembrane receptors
including the integrins and the superfamily of cell-surface pro-
teoglycans (10, 11). The identity of the receptor-ligand pairing
defines the composition of focal adhesions and the participants
of intracellular signaling (10). For example, plating cells onto
the principle adhesive ligands Arg-Gly-Asp (RGD), which bind
to integrin receptors, was shown to induce the formation of
nascent focal adhesions but failed to form stress fibers and/or a
cytoskeletal network (12, 13). Only with the co-stimulation of
cell surface heparan sulfate proteoglycans (HSPGs) by the addi-
tion of soluble FN heparin-binding polypeptide did cells form
mature focal contacts on the cell binding domain of FN (12).
Themajor group of HSPGs is the syndecans that have a distinc-
tive pattern of expression characteristic for a particular cell type
(11). Of the fourmembers of the syndecan family, syndecan-4 is
the only member that is ubiquitously expressed and has been
shown to be present in focal contacts. By direct binding to FN,
syndecan-4 cooperateswith integrin51 in focal adhesion for-
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mation and actin cytoskeleton organization as demonstrated in
various anchorage-dependent cell lines (11, 14).
TG2 can enhance the cell attachment and spreading of a
number of different cell types through themodification of ECM
proteins by their cross-linking (15, 16). However, recent reports
also describe a non-transamidating mechanism whereby TG2
acts as a novel cell adhesion protein (6, 17) thought to involve
direct interaction with a variety of integrin receptors. The
importance of TG2 as a wound response enzyme, particularly
with respect to its role as a matrix-associated protein, is well
reported (7, 18). Under these conditions, a TG2-rich FNmatrix
(TG-FN) may be found in which increased deposition of TG2
either by secretion from surrounding cells or via disruption of
incoming red blood cells occurs at injury sites where TG2 binds
to FN with high affinity. Using a TG-FN matrix or a cell-se-
creted TG2 rich matrix, we showed that this complex could
restore loss of cell adhesion and promote cell survival in both
fibroblasts and osteoblast after the inhibition of the classical FN
RGD-dependent cell adhesion pathway mediated by 51 inte-
grin receptors (19). Such a process would be important during
tissue injury and duringmatrix remodeling where disruption of
FN and other matrix proteins leads to generation of soluble
RGD-containing peptides which can compete for matrix cell
binding sites, potentially leading to anoikis (7, 20). We previ-
ously demonstrated that RGD-independent cell adhesion to the
TG-FN complex did not require transamidating activity but
induced the formation of focal adhesion contacts, the assembly
of associated actin stress fibers, and FAK phosphorylation (19).
In this previous study, we demonstrated that the digestion of
cell surface heparan sulfate chains significantly reduced the cell
adhesion to TG-FN after RGD inhibition, suggesting the
involvement of a HSPG receptor (19).
Here we report that the TG-FN complex promotes RGD-
independent cell adhesion through binding to the heparan sul-
fate chains of syndecan-4. This novel pathway requires interac-
tion of PKC with 1 integrin and induces FAK and
extracellular signal-regulated kinase (ERK) activation. Further-
more, we demonstrate that the ablation of c-Raf-1 diminishes
the ability of a TG-FN matrix to rescue cell adhesion in the
presence of RGD-containing peptides.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies—Human plasma fibronectin was
purchased from Sigma-Aldrich. The FN synthetic peptides
GRGDTP and GRADSP were from Calbiochem. Integrin Sam-
pler antibody kit containing rabbit anti-integrin 1,3,5 was
purchased from Insight Biotechnology; anti-integrin 4 anti-
body (P1H4) was from Chemicon; mouse anti-human FAK,
mouse anti-phospho-ERK, mouse anti-PKC were from Santa
Cruz; the mouse anti--tubulin, and rabbit anti-actin antibod-
ieswere fromSigma-Aldrich; anti-FAKTyr(P)397 andTyr(P)861
were from Upstate Cell Signaling Solutions and BIOSOURCE,
respectively. The rabbit polyclonal anti-syndecan-4 was from
Zymed Laboratories Inc. Purified guinea pig liver TG2 was
purified according to Leblanc et al. (21). The GK-21 peptide
(GENPIYKSAVTTVVNPKYEGK) and the scrambled control
peptide (GTAKINEPYSVTVPYGEKNKV) were chemically
synthesized in tandem with the antennapedia third helix
sequence (RQIKIWFQNRRMKWKK) by Peptide Protein
Research. The irreversible active-site directed inhibitor R283
(1,3-dimethyl-2-[(2-oxopropyl)thio] imidazolium chloride) (4,
22), was synthesized at Aston University.
Cell Lines—Swiss 3T3 fibroblasts transfected with TG2
cDNA under tetracycline repressible promoter were cultured
in Dulbecco’s modified Eagle’s medium as we previously
described (23). The CHO-K1 cell line was purchased from
ATCC and grown inHam’s F-12medium according to the sup-
plier’s instructions. Primary mouse embryonic fibroblasts iso-
lated from syndecan-4 wild type (wt)/knock out (ko) mice and
1 integrin wt/ko mice along with syndecan-4 and 1 integrin
ko mouse embryonic fibroblasts stably transfected back with
wild type syndecan-4 and 1 integrin cDNA, respectively (sup-
plemental Table 1), were provided by Prof. M. J. Humphries
(University ofManchester,Manchester, UK) andmaintained in
Dulbecco’s modified Eagle’s medium as published. The PKC
binding mutant syndecan-4 ko cells transfected with Y188L
human syndecan-4 were cultured as described (24). The 3T3-
like fibroblast cell lines derived from E12.5 Raf-1 ko and wt and
stable Raf-1 ko cell clones expressing full-length kinase-compe-
tent of Raf-1 (KC3) or a kinase-dead domain of Raf-1 protein
were gifts of Manuela Baccarini (University of Vienna, Vienna,
Austria) and were cultured as described previously (25).
Cell Adhesion Assay—Cell adhesion assays were performed
as described before (19). Briefly, tissue culture plastic was
coatedwith 1g of FNper cm2 overnight at 4 °C.After blocking
of the FN matrix in 3% (w/v) Marvel, 2 g of guinea pig liver
TG2 per cm2 was immobilized on FN matrix. Before experi-
ments, cells were starved by the reduction of serum concentra-
tion to 2% (v/v) for 18 h before experiments. After the detach-
ment of cells from their substratum with trypsin, they were
washed twice in serum-free growth media, pretreated with
GRGDTP and GRADSP control peptide, and seeded on matri-
ces at a density of 6  104 cells/cm2. In adhesion assays with
Swiss 3T3 fibroblasts transfected with TG2, phosphate-buff-
ered saline containing 2 mM EDTA, pH 7.4, was used for non-
enzymatic detachment, which enabled cells to retain the cell
surface-associated TG2 (4). Based on previous toxicity findings
(19), adhesion experiments were performed using 75–150
g/ml RGD synthetic peptide, leading to partial inhibition in
cell adhesion. In heparin treatment studies, bound FN was first
incubatedwith heparin in a 60-fold excess of the FNbeforeTG2
immobilization. The amount of immobilized TG2 on the hep-
arin-blocked FN matrix was shown to be comparable with the
untreated TG-FN matrix using a modified enzyme-linked
immunosorbent assay as described previously (19). Cells were
allowed to attach for 20–40 min to minimize the secretion of
any endogenous proteins. Cells were fixed, permeabilized, and
stained, and digital images per each sample were acquired as
stated before (19). The cell attachment and spreading were
quantified, and the number of cells per image was assessed as
described previously (19).
Immunoblotting and Co-immunoprecipitation—Swiss cells
grown to 70% confluency and serum-starved for 18 h were
trypsinized and then plated onto 6-well plates coated with FN
or TG-FN matrices at a density of 6 105 cells per well. After
the treatment with RAD/RGD-containing peptides, cells were
Fibronectin-TG2Matrix Signaling
20938 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 30•JULY 25, 2008
 at A
STO
N
 U
N
IV
ERSITY
 on N
ovem
ber 1, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
allowed to attach for 30min. For detection of basal and tyrosine
phosphorylation levels of MAPKs, cells were lysed by the addi-
tion of 50 l of solubilization buffer (1% (v/v) Nonidet, 0.5%
(w/v) sodium deoxycholate, 0.1% (w/v) SDS, 1 mM benzami-
dine, 1 mM NaF, 1 mM Na3VO4, 0.1 mM PMSF and 1% (v/v)
protein inhibitor mixture). Cell extracts were clarified by fur-
ther centrifugation at 300  g for 5 min at 4 °C and stored at
70 °C. Equal amounts of proteinwere electrophoretically sep-
arated and transferred to a nitrocellulose membrane. The
nitrocellulose membranes were blocked and probed with the
antibodies of interest as described previously (19). For co-im-
munoprecipitation, cells were plated onto TG-FN where the
FN was first blocked with heparin as described above. Cells
were lysed in lysis buffer containing 0.25% sodium deoxy-
cholate, 150 mM NaCl, 0.1 mM phenylmethylsulfonyl fluoride,
1% (v/v) protein inhibitor mixture (Sigma-Aldrich), 500 M
R283 TG2 specific inhibitor, and 50 mM Tri-HCl, pH 7.4, and
put on ice for 30 min with occasional mixing. 200 g of cell
extract was then precleared for 1 h at 4 °C with nonspecific
rabbit IgG followed by 90 min of incubation with 50 l of pro-
tein A-Sepharose bead slurry on a rocking platform. Precleared
cell lysates were then incubated with 0.5 g of rabbit anti-syn-
decan-4 antibody for 90 min at 4 °C. Immune complexes were
precipitated with 50 l of protein A-Sepharose bead slurry for
2 h at 4 °C, washed with lysis buffer, and extracted in Laemmli
sample buffer. Samples were resolved by 8% SDS gel electro-
phoresis, transferred to nitrocellulosemembrane and immuno-
probed with mouse monoclonal anti-TG2 Cub7402 antibody
(Lab Vision Corp.) or anti-1 integrin antibody as described
previously (4).
Immunofluorescence Staining—Subconfluent mouse embry-
onic fibroblasts were serum-starved for 16 h, harvested, and
pretreated with 100 g/ml GRADSP or GRGDTP peptides as
described above. Cells were seeded in 8-well glass chamber
slides (8  104 cells/well) previously coated with FN and
TG-FN and allowed to attach and spread for 40min. Cells were
fixed and permeabilized as described previously (19). For stain-
ing of actin stress fibers, cells were blocked in phosphate-buff-
ered saline supplemented with 3% (w/v) bovine serum albumin
and then incubated with fluorescein isothiocyanate-labeled
phalloidin (20 g/ml) in blocking buffer. Coverslips were
mounted with Vectashield mounting medium and using con-
stant photomultiplier tube and section depth settings, nine ran-
dom fields/sample were captured by Zeiss LSM510 laser con-
focal microscopy using Zeiss LSM Image Browser.
Statistics—Data were expressed as the mean  S.D. The
data shown are derived from mean of at least three experi-
ments (n  3) undertaken in triplicate. The comparisons
between the data sets were performed using Student’s t test
(two-tailed distribution with equal variance). Statistical sig-
nificant difference between data sets was defined in the text
by a p  0.05 (two-sided).
RESULTS
FN-bound TG2 Requires Association with Cell Surface Hepa-
ran Sulfate Chains for RGD-independent Cell Adhesion—Our
previous data (19) suggested an interaction between TG-FN
complex and cell surface HSPG receptors in RGD-independent
cell adhesion; however, the relative contribution of the two pro-
teins to this process is not known. Heparin binding sites in FN
that can be recognized by HSPG receptors were, therefore,
blocked as described (26) by excess soluble heparin before TG2
immobilization. The ability of FN-bound TG2 (TG-FN) to
mediate RGD-independent cell adhesionwas then investigated.
Attachment and spreading onFNalonewas sensitive to heparin
blocking (Fig. 1A). The heparin-blocked FN matrix, for exam-
ple, could only support 75% of control cell adhesion seen on
FN matrix alone. Inhibition of cell adhesion by RGD-contain-
ing peptides was alsomore effective on the heparin-blocked FN
matrix. In contrast, once TG2was immobilized on the heparin-
blocked FNmatrix, it compensated for the loss of cell adhesion
both in the presence or absence of RGD peptide.
Evidence suggests that the protein ectodomain and the hepa-
ran sulfate chains of HSPGs can support cell attachment and
spreading through distinct pathways (27–29). To further eluci-
date the nature of the TG-FN interaction with HSPGs, a well
characterized CHO-K1 cell mutant totally deficient in heparan
sulfate synthesis (HSCHO-K1) was used in the cell adhesion
assays (Fig. 1, B and C). Wild type and mutant CHO-K1 cells
displayed a comparable cell attachment on FN and TG-FN
matrix, but the HSCHO-K1 cells failed to spread on these
matrices. Incubation with RGD peptide effectively blocked cell
adhesion of wt and mutant CHO-K1 cells on FN matrix.
Although wt cells could restore RGD-impaired cell adhesion
when plated on a TG-FN matrix, the heparan sulfate mutant
cells limited attachment but failed to spread on TG-FN in the
presence of RGD.
TG-FNDoes Not Support RGD-independent Cell Adhesion in
Syndecan-4 Null Fibroblasts—Although cells can adhere and
spread on the integrin binding domain of FN (RGD and central
binding domain of FN), they fail to form complete focal adhe-
sion contacts and reorganize the actin cytoskeleton unless syn-
decan-4 is activated (12, 30). To test whether the ubiquitous
syndecan-4 is the HSPG receptor responsible for RGD-inde-
pendent cell adhesion on TG-FN,mouse embryonic fibroblasts
isolated from syndecan-4 wild type (sdc4 wt) and knock out
(sdc4 ko) mice were used in cell adhesion assays. sdc4 wt fibro-
blasts plated on the FN matrix became well attached and
spread, whereas sdc4 ko fibroblasts exhibited a slight delay in
attachment and spreading in the short-term adhesion assays
(20 min) losing as much as 20% of the original cell adhesion to
FN (p 0.05, Fig. 2A). 1 h after seeding on FN, the percentage
of sdc4 ko cells that are spreadwith organized actin stress fibers
were not statistically different than thewild type cell line (Fig. 2,
A and B). Syndecan-4 null cells did, however, exhibit a reduc-
tion in longitudinal stress fibers and formed stress fiber bundles
that were more restricted to the cell periphery compared with
the wild type. The RGD peptide reduced cell adhesion of sdc4
wt fibroblasts on FN up to 60% of the cell adhesion recorded on
the FN matrix alone in the presence of RAD peptide (control
values). Sdc4 ko cells appeared to be more sensitive to RGD
inhibition, and cell attachment and spreading on FN was
decreased by 70–80% that of control values, respectively (Fig.
2A). RGD-impaired cell adhesion and the observed diffused
actin cytoskeletal architecture was rescued only in the sdc4 wt
cells seeded on the TG2-bound FN matrix, whereas sdc4 ko
Fibronectin-TG2Matrix Signaling
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cells failed to respond to this matrix. To confirm that the per-
turbation of RGD-independent cell adhesion of sdc4 ko fibro-
blasts on TG-FN was because of a deficiency in syndecan-4
expression, sdc4 ko fibroblasts were transfected with synde-
can-4 cDNA (sdc4 ab) or empty vector (sdc4 vec) (supplemen-
tal Fig. 1) (24). The reintroduction of syndecan-4 to sdc4 ko
fibroblasts rescued the delayed cell attachment and spreading
on FN (Fig. 2A) and enabled formation of typical actin stress
fibers on FN (Fig. 2B). Importantly, sdc4 ab cells were able to
respond to TG-FN matrix and
mediate RGD-independent cell
adhesion with well organized actin
stress fibers.
To show direct interaction of
TG2 with syndecan-4 during RGD-
independent cell adhesion, we
immunoprecipitated the synde-
can-4 TG2 complex. For this pur-
pose, sdc4 wt, sdc4 ko, and sdc4 ab
cells were treated with the RGD-
containing peptide and seeded on a
heparin-blocked FN matrix to
which TG2 was bound. Thereby, we
blocked the interaction of synde-
can-4 with the heparin binding sites
in FN, leaving only TG2 to associate
with the receptor. Immunoprecipi-
tation of syndecan-4 followed by
immunoblotting for TG2 revealed
the coimmunoprecipitation of TG2
(Fig. 2C), further confirming that
TG2 in the TG-FN complex inter-
acts directly with syndecan-4 to
mediate an RGD-independent cell
adhesion.
PKC Activity and Its Interaction
with 1 Integrins Is Essential in
RGD-independent Cell Adhesion
Signaling—Engagement of synde-
can-4 with ECM proteins recruits
PKC to the plasma membrane and
activates this serine-threonine
kinase through a direct interaction
between the cytoplasmic domain of
the receptor and the catalytic
domain of the enzyme (31). The
inhibition of PKCwith the specific
inhibitor Go6976 reduces the adhe-
sion of human osteoblasts (19) and
Swiss 3T3 (supplemental Fig. 2A) to
FN and blocked the RGD-inde-
pendent cell attachment and
spreading in response to TG-FN,
signifying the importance of this
kinase in the signaling process. In
addition, membrane fractionation
experiments showed that the
decrease in PKC membrane levels
in cells seeded on FN due to RGD inhibition was pulled back
nearly to control levels when cells were seeded on TG-FN
matrix (supplemental Fig. 2B).
To further confirm the involvement of syndecan-4-depend-
ent PKC regulation in RGD-independent cell adhesion signal-
ing, we performed cell adhesion experiments using syndecan-4
ko cells expressing a PKC binding mutant syndecan-4 (sdc4
Y188L) (24). sdc4 Y188L fibroblasts demonstrated similar
adhesion on FNandTG-FN to sdc4 ko cells in that they failed to
FIGURE 1. TG2 bound to FN supports RGD-independent cell adhesion through heparan sulfate chains.
Each data point corresponds to themean percentage of attached cells (cell attachment) or themean percent-
age of spread cells (cell spreading) S.D. of at least three separate experiments performed in triplicate. Total
cells analyzed in control samples were500. A, adhesion of Swiss 3T3 cells on FN and TG-FN2matrices with or
without heparin block in the presence of RAD or RGD (100 g/ml) peptide. Cell attachment and spreading is
expressed as the mean percentage of attachment of RAD-treated cells on the FN matrix without heparin
block S.D., which represents 100%. B and C, response of CHO-K1 wt and heparan sulfate-deficient mutant
HS-CHO-K1mutant cells to TG-FNmatrix. CHO-K1wt and HS-CHO-K1 cells in suspensionwere pretreatedwith
RAD (150g/ml) and RGD (100 and 150g/ml) peptides before seeding on either FN or TG-FN.Mean percent-
age value of CHO-K1 wt attached and spread cells on FN S.D. (control) was set at 100%. Bar, 20 m.
Fibronectin-TG2Matrix Signaling
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attach and spread on TG-FN in the presence of RGD (Fig. 3A).
This result suggested that inhibition of the syndecan-4-
dependent PKC activation and membrane translocation by
TG-FN abolishes the TG-FN-mediated RGD-independent cell
adhesion.
Syndecan-4 signals cooperatively with integrin during inte-
grin-mediated cell adhesion onFN.Hypothetically,1 integrins
might, therefore, also be involved in TG-FN-mediated, RGD-
independent cell adhesion but via a process involving inside-
out signaling. Although themechanism behind syndecan-4 and
1 integrin cross-talk remains to be revealed, evidence suggests
PKC is a possible link protein between the two receptors (24,
32–34). The PKC binding site on1 integrin has beenmapped
in the distal region of 1 cytoplasmic tail (amino acids 783–
803). Based on this sequence, a 21-amino acid peptide (GK-21)
mimicking the 1 cytoplasmic tail was synthesized in tandem
with the antennapedia third helix sequence and shown to per-
turb PKC and 1 integrin interaction and block cancer cell
chemotaxis by hindering PKC (35). Using a similar approach,
Swiss 3T3 fibroblasts were pretreated with cell-permeable pep-
tide GK-21 (permeability shown in the supplemental Fig. 2B)
and scrambled control peptide (CP) before plating on FN and
TG-FN matrices in the presence of RGD and RAD-containing
peptides. Disruption of PKC interaction with 1 integrins led
to a significant (30%) decrease in cell adhesion on FN (p 0.05),
but more importantly, it ablated the RGD-independent cell
adhesion on TG-FN (Fig. 3B). Immunofluorescence visualiza-
tion of the actin stress fibers by confocal microscopy revealed
that GK-21 treatment resulted in a less well developed actin
cytoskeleton structure in Swiss 3T3 fibroblasts on FN. Only
60% of GK-21-treated cells assembled actin stress fibers on FN
that were somewhat less dense than those seen in CP-treated
cells on FN (Fig. 3C). Furthermore, GK-21-treated cells adher-
ing to TG-FN did not show organized stress fibers after RGD
FIGURE 2. The selective loss of syndecan-4 abolishes the TG-FN2-mediated RGD-independent cell adhesion. The percentage of attached cells or the
percentage of spread cells S.D. shown are from themean of at least three independent experiments, performed in triplicate. Total number of cells analyzed
per experiment in control samples was 340. A, syndecan-4 wild type (sdc4 wt) and knock out (sdc4 ko) fibroblasts and syndecan-4 ko fibroblasts stably
transfectedwith human syndecan-4 cDNA (sdc4 ab) ormock vector (sdc4 vec) were treatedwith RADor RGDpeptide (100g/ml) and seeded on FN and TG-FN
matrices for 20 min. The mean cell attachment and spreading values were expressed as the percentage of control values of sdc4 wt cells seed on FN (which
represents 100%) S.D. in the presence of RAD. B, actin stress fiber formation in sdc4 wt, ko, and ab cells on TG-FN in the presence of RGD peptide. Cells were
treatedwith 100g/ml RAD and RGDpeptide and seeded on FN and TG-FNmatrices (FN, RGD, and RGD-TG, respectively), and actin stress fiber formationwas
visualized as described under “Experimental Procedures.” At least 150 cells were imaged for the control sdc4 wt cells seeded on FN in the presence of RAD
peptide. Data shown are from a representative experiment, indicating themean percentage of cells with formed actin stress fibers expressed as percentage of
control values. Bar, 20m. C, lysates of cells sampleswere immunoprecipitatedwith anti-syndecan-4 andWestern-blotted for TG2 (75kDa) as described under
“Experimental Procedures.” TG2 isolated from guinea pig liver (TG2) was loaded to the first lane as the internal standard.
Fibronectin-TG2Matrix Signaling
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inhibition compared with CP-treated cells, which exhibited
stress fiber assembly.
TG-FN-mediated RGD-independent Cell Adhesion Requires
the Activation of 1 Integrins—To establish a role for 1 inte-
grins in the TG-FN-mediated RGD-independent cell response,
1 integrin null mouse embryonic fibroblasts (1 ko) and 1 ko
cells transfected with 1 integrin cDNA (1 ab) and empty vec-
tor (1 vec) (36) were used. Because
TG2 can associatewith other inte-
grins like 3 (6) and 5 (37), the lev-
els of these integrins weremeasured
and found to be comparable among
these cells (supplemental Fig. 3 and
Table 1). The 1 ko and 1 vec cells
displayed a 2-fold reduction in cell
adhesion on FN in comparison to1
wt in short term adhesion assays (30
min). The adhesive response of the
1-deficient cells to FN was much
more susceptible to inhibition by
RGD peptide than that of cells
expressing 1 integrin (Fig. 4, A and
B). The 1-deficient cells also failed
to mediate RGD-independent cell
adhesion on TG-FN, whereas the
attachment and spreading was
restored in 1 wt and 1 ab cells on
TG-FN in the presence of RGD,
strongly indicating that 1 integrin
is required for the RGD-independ-
ent cell adhesion in response to
TG-FN. To investigate a possible
direct interaction between synde-
can-4 and 1 integrins via the syn-
decan-4 core protein (38) during
TG-FN mediated RGD-independ-
ent cell adhesion, we immunopre-
cipitated syndecan-4 in sdc-4wt, ko,
and ab cells seeded on the heparin-
blocked TG-FN matrix in the pres-
ence of RGD. Immunoblot analysis
of the precipitates with anti-1 inte-
grin antibody revealed that synde-
can-4 did not interact with integrin
1 (Fig. 4C).
Cell-ECM adhesion mediated by
syndecan-4 and 1 integrins gener-
ates intracellular signals stimulating
a number of non-receptor tyrosine
kinases (34), notably FAK, followed
by the activation of the MEK (mito-
gen-activated protein kinase/extra-
cellular signal-regulated kinase
kinase)/ERK cascade. FAK activa-
tion by adhesion receptors involves
phosphorylation of up to six differ-
ent tyrosine residues (39). Initial
activation involves FAK autophos-
phorylation at Tyr397, which was shown to take place during
RGD-independent cell adhesion to TG-FN in human
osteoblasts (19). We, therefore, analyzed the autophosphoryla-
tion of FAK (Tyr397) alongwith tyrosine phosphorylation at 861
(Tyr861) in Swiss 3T3 fibroblasts (Fig. 4C). Phosphorylation at
Tyr397 and Tyr861 in FAK was markedly reduced when cells
were seeded on bovine serum albumin or on FN in the presence
FIGURE 3. The importance of PKC activity in RGD-independent cell adhesion on TG-FN matrix. A, syn-
decan-4 wild type (sdc4 wt) and knock out fibroblasts expressing Y188Lmutant syndecan-4 (sdc4 Y188L) were
plated on FN and TG-FNmatrices in the presence of control RAD and RGDpeptide (100g/ml). Mean percent-
age value of sdc4wt cells attached and spread on FN in the presence of RAD S.D. (control) was used as 100%.
B, site-directed disruption of PKC and -1 integrin interaction ablates the RGD-independent cell adhesion in
response to TG-FN. Swiss 3T3 cellmonolayerswerepreincubatedwith 8MscrambledCPandGK21peptide (in
serum free medium) for 1 h and seeded on FN and TG-FN matrices after RAD and RGD (100 g/ml) peptide
treatment. Mean percentage value of non-treated (NT) attached and spread cells on FN in the presence of
RAD  S.D. (control) was used as 100%. C, PKC and 1 integrin cross-talk is necessary for the formation of
actin-stress fibers during the RGD-independent cell-adhesion. CP- and GK21-treated Swiss 3T3 cells on FN and
TG-FNmatriceswere scored for actin stress fiber formation in thepresenceofRADandRGDpeptides. Themean
percentage S.D. of cells, which formed mature stress fibers, is shown.
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of RGD. However, phosphorylation of both residues in
response to TG-FN was increased to a level comparable with
control cells on FN. Western blots performed in parallel
showedno significant change in the total FAK levels in the same
protein extracts. Because FAK phosphorylation at Tyr861 is
induced by integrin clustering and does not require integrin-
ligand engagement (40), these data suggests that RGD-inde-
pendent adhesion via TG-FN promotes FAK phosphorylation
due to up-regulation of both cell-matrix interactions and inte-
grin clustering through inside-out signaling.
Anchorage-dependent activation of FAK is followed by the
activation of ERK.We, therefore, monitored ERK1/2 activity in
TG-FN induced RGD-independent
cell adhesion using phospho-spe-
cific ERK1/2 antibodies (Fig. 4C).
Western blot analysis revealed that
loss of cell adhesion on bovine
serum albumin or on FN matrix
with RGD led to 2-fold reduction in
tyrosine phosphorylation levels of
ERK1 and ERK2 (p-ERK1/2), in
comparison to the levels recorded
for cells on FN. However, a robust
increase in ERK1/2 phosphoryla-
tion was observed in cells plated on
TG-FN in the presence of RGD,
suggesting that ERK1/2 activation is
involved in adhesion signals that are
transduced by TG-FN in an RGD-
independent manner.
Loss of Raf-1 Impairs the Restora-
tion of Cell Adhesion by TG-FN—
The fundamental role of RhoA in
TG-FN-driven RGD-independent
cell adhesion was illustrated by fail-
ure in assembly of actin stress fibers
after C3 exotransferase treatment
(19). Recent evidence supports a
link between Rho regulation and
Raf-1 kinase in cell adhesion signal-
ing during wound healing, as Raf-1-
deficient fibroblasts demonstrate a
defect in actin cytoskeleton organi-
zation on FN (25). We performed
cell adhesion assays using Raf-1
deficient (Raf-1 ko) and wild-type
(Raf-1 wt) fibroblasts to determine
the role of Raf-1 in RGD-independ-
ent cell adhesion in response to
TG-FN. Once attached and spread
on FN and/or TG-FN, Raf-1 wt cells
displayed a Swiss 3T3 fibroblast-like
appearance. However, Raf-1 ko cells
demonstrated a non-homogenous
morphology with flattened spindle-
like cells and cuboidal cells (Fig. 5B)
(25). Moreover, Raf-1 ko cells
attached and spread 56% less on
FN compared with wt cells (Fig. 5A). The treatment of Raf-1 wt
and ko cells with 100 g/ml RGD peptide resulted in a 60%
decrease in attachment and a 50% decrease in spreading on FN
matrices. When RGD-independent cell adhesion was analyzed
on TG-FN, Raf-1 wt cells were able to restore their attachment
and spreading nearly to control levels, whereas Raf-1 ko cells
displayed no significant (p  0.05) increase in cell adhesion,
indicating that Raf-1 is necessary for the rescue of RGD-inde-
pendent cell adhesion by the TG-FN complex. Next, we inves-
tigatedwhether the kinase activity of Raf-1 was necessary for its
function in the RGD-independent pathway using stable Raf-1
ko fibroblasts cell lines which express full-length kinase-com-
FIGURE4. Importanceof1 integrin function in the supportof theRGD-independent cell adhesion.A and
B,1 integrinwild type (1wt) and knock out (1 ko) fibroblasts and1 integrinko fibroblasts stably transfected
with human 1 integrin cDNA (1 ab) or mock vector (1vec) were pretreated with RAD or RGD peptide (100
g/ml) and seeded on FN and TG-FN matrices. Cell adhesion is expressed as the mean percentage of attach-
ment and spreadingof1wt cells on the FNmatrix (in the presence of RAD) S.D., which represents 100%and
signifies the mean of at least three experiments performed in triplicate. Total number of cells analyzed in
control samples was450. Bar, 20 m. C, lysates of syndecan-4 wild type (sdc4 wt) and knock out (sdc4 ko)
fibroblasts and syndecan-4 ko fibroblasts stably transfected with human syndecan-4 cDNA (sdc4 ab) were
immunoprecipitated with anti-syndecan-4 andWestern-blotted for 1 integrin (130 kDa). The first lane shows
the 1 integrin control (1 control). D, Swiss 3T3 fibroblasts were treated with 100 g/ml RAD or RGD peptide
and seeded on bovine serum albumin (BSA), FN, and TG-FN matrices. Lysates of cells samples were Western-
blotted and probed with FAK antibodies (125 kDa) for tyrosine phosphorylation at 397 and 861 and ERK1 (44
kDa) and ERK2 (42 kDa) antibody for phosphorylation at tyrosine 204. Equal loading was ensured by probing
the blots with anti--tubulin antibody.
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petent Raf-1 (KC3 cells) and the kinase-dead domain of Raf-1
(KD4 cells) along with V8 cells that are transfected with the
empty vector. Re-expression of the full-length Raf-1 and
kinase-dead domain of Raf-1 in Raf-1 ko cells restored both the
cellmorphology (Fig. 5B) and the level of cell adhesion (Fig. 5A).
V8 cells showed no morphological difference to Raf-1 ko cells
and displayed comparable cell adhesion pattern. RGD peptide
reduced the cell attachment and spreading of KC3 and KD4
cells on FN to levels similar to those recorded for the wild type
fibroblasts. The RGD-impaired cell adhesion was restored on
TG-FN in KC3 and KD4 cells, indicating that the physical pres-
ence of Raf-1, but not its kinase activity, is required in TG-FN-
mediated cell adhesion.
DISCUSSION
In our previous paper we demonstrated that when cells such
as fibroblasts, osteoblasts, and endothelial-like cells were plated
on a TG-FN complex they were capable of mediating an RGD-
independent cell adhesion process via cell surfaceHSPGs, since
digestion of cell surface HS chains inhibited the RGD-inde-
pendent cell attachment and spreading on TG-FN (19). Our
initial objective in this paper was, therefore, to identify the
HSPG involved in this interaction with TG-FN and to deter-
mine whether this interaction is mediated directly via binding
of the HSPG to TG2 as TG2 is known to have a high affinity for
heparin (15). First we show that CHO-K1 cells deficient in syn-
thesis of HS chains did not attach or spread on TG-FN in an
RGD-independent manner, confirming the importance of HS
chains in this process. To indicate that the interaction with the
cell surface HS chains was via TG2
rather than FN, we demonstrate
that saturation of the heparan sul-
fate binding sites on the FN matrix
with the heparan sulfate analogue
heparin before TG2 immobilization
did not inhibit the RGD-independ-
ent adhesion of Swiss 3T3 cells to
this matrix. Hence, during RGD-in-
dependent cell adhesion, associa-
tion of FN-bound TG2 with HS
chains could be the sole receptor
ligand interactionHowever, we can-
not rule out that the binding of FN-
bound TG2 to the HS chains could
also reinforce/expose cryptic sites
on FN that are recognized by other
unknown receptors or by the synde-
can-4 core domain (38), leading to
the stabilization of the TG-FN
interaction with HSPGs.
Among the heparan sulfate pro-
teoglycans, syndecan-4 is the most
ubiquitous (11) and has been found
in focal contacts acting in coopera-
tion with integrins in a Rho and
PKC-dependent manner (41).
Using sdc-4 ko, wt, and sdc-4 add-
back fibroblasts in syndecan-4
immunoprecipitation studies, we demonstrate that FN-bound
TG2 is directly associatedwith syndecan-4. Importantlywe also
show that deletion of syndecan-4 in fibroblasts abrogated the
RGD-independent cell adhesion and actin stress fiber forma-
tion on the TG-FNmatrix. This could be restored when synde-
can-4 was transfected back into these cells, indicating that syn-
decan-4 is the HSPG responsible for binding the TG-FN
complex when 51 integrins are blocked with RGD peptide.
Finally, in agreement with the results obtained from CHO-K1
mutant cells, heparitinase treatment of sdc-4 wt cells produced
a morphology similar to that of sdc-4 ko cells and blocked the
response to the TG-FN matrix (data not shown). These results
confirm that syndecan-4 is the primary receptor thatTG2binds
towhen complexedwith FN and that this interaction is with the
HS chains rather than the core protein of syndecan-4.
Having shown that TG2 associates with syndecan-4, we next
investigated the downstream signaling pathway to gain amech-
anistic insight into RGD-independent cell adhesion. We dem-
onstrate that PKC and -1 integrin activation are both impor-
tant in the TG-FN-mediated RGD-independent pathway. First,
the inhibition of cell adhesion by the RGD peptide and treat-
ment of cells with the PKC inhibitor Go6976 led to a substan-
tial decrease in the membrane levels of PKC accompanied by
diminished RGD-independent cell adhesion on TG-FN. Sec-
ond, syndecan-4 ko cells transfected back with PKC-binding
mutant syndecan-4 cDNA were unable to support RGD-inde-
pendent cell adhesion. Third, treatment of fibroblasts with
the GK-21 inhibitory peptide that is known to block the asso-
ciation between PKC and 1 integrin cytoplasmic domain
FIGURE 5.Adhesionof Raf-1wt andRaf-1 ko fibroblasts to FNandTG-FNmatrices in thepresenceof RAD
andRGDpeptides.A andB, Raf-1wild type (Raf-1wt) and knockout (Raf-1 ko) 3T3-like immortalized fibroblast
cell lines and stable clones of Raf-1 ko cells expressing either full-length kinase-competent of Raf-1 (KC3) or a
kinase-dead domain of Raf-1 protein (KD4) as well as empty vector (V8) were pretreated with RAD and RGD
peptide (100 g/ml) and allowed to attached on FN and TG-FNmatrices. Data represents the means percent-
age attachment and spreading S.D. of triplicate wells from four experiments. The total number of cells
analyzed for the control sample was400. The ordinates of the graphs represent the mean cell attachment
and spreadingexpressedasmeanpercentageof control attachmentof Raf-1wt fibroblasts onFN S.D.,which
represents 100%. Bar, 20 m.
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(35) reduced the RGD-independent cell adhesion and asso-
ciated stress fiber formation. Finally, 1 integrin null fibro-
blasts, although expressing other TG2-associating integrins
(3 and 5), could not to respond to the TG-FN matrix.
Taken together, these data indicate that syndecan-4-driven
stimulation of PKC and subsequent association and activa-
tion of 1 integrins is necessary for cell adhesion and forma-
tion of actin bundling in cells that adhere on TG-FN in the
presence of RGD.
The TG-FN-mediated RGD-independent cell adhesion via
syndecan-4 differs from the classical cell adhesion to FN, where
formation of focal adhesions and actin stress fibers is integrin-
initiated but syndecan-4-dependent. In RGD-independent cell
adhesion, syndecan-4 acts as the primary receptor, and its phys-
ical interaction with FN-bound TG2 but not with 1 integrin
leads to PKC-induced 1 integrin activation, which is in turn
necessary for actin stress fiber orga-
nization. A comparable novel adhe-
sion pathway has been recently
reported in which the cysteine-rich
domain of the disintegrinADAM12
can support cell adhesion and actin
stress fiber formation through syn-
decan-4-driven PKC signaling in a
1 integrin-dependentmanner (42).
However, the RGD-independent
cell adhesion pathway demon-
strated TG2 binding to synde-
can-4 is different from that medi-
ated by ADAM 12 in that, unlike
the ADAM 12 mechanism, it does
not require additional outside in
activation of 1 integrins with
activating antibodies. In the case
of TG-FN-mediated signaling via
syndecan-4, the process itself can
activate 1 integrins by prompting
intracellular cross-talk between
syndecan-4 and 1 integrin, re-
sulting in cell spreading.
The architecture of the actin
cytoskeleton depends on the acti-
vation status of the Rho GTPase
family members, mainly RhoA.
The introduction of RhoA inhibi-
tor C3 exotransferase was demon-
strated previously to abolish RGD-
independent actin cytoskeleton
organization and focal adhesion
formation, indicating that our
model pathway relies on regula-
tion of RhoA (19). We, therefore,
propose that in RGD-impaired cell
adhesion, FN-bound TG2 engage-
ment by syndecan-4 causes PKC-
driven modulation of RhoA and
stress fiber bundling in a 1 inte-
grin-dependent manner. This
mechanisticmodel agrees with the data of Dovas et al. (43) who
suggested a linear pathway, whereby signaling though synde-
can-4, PKC, andRhoA is required for the formation andmain-
tenance of actin stress fibers in fibroblasts. RhoA cooperates
with downstream effectors Rok- and mDIA to promote the
formation of actin stress fibers. It is now recognized that Rok-
associates with c-Raf-1 kinase and regulates RhoA-mediated
signaling in fibroblasts (25). The mechanism of Raf-1 regulated
Rho signaling is yet to be determined, but our data indicate
Raf-1 to be important in the RGD-independent cell adhesion
pathway since the Raf-1 ko fibroblasts do not support TG-FN
mediated RGD-independent cell adhesion unless transfected
with full-length or kinase-inactive domain Raf-1. We, there-
fore, anticipate that the Raf-1 protein is essential for the signal-
ing pathway mediated by TG-FN and regulates this pathway in
a Rho-dependent manner via a protein-protein interaction.
FIGURE 6. Summary of proposed TG-FNmediated RGD-independent cell adhesion pathway. After tissue
damage and/or remodeling, degradation of the ECM leads to formation of RGD-containing FN fragments
which can compete for the RGD-dependent cell binding sites ultimately leading to loss of cell adhesion and
anoikis. FN-bound TG2 (TG-FNheterotropic complex)with increased resilience toMMPdegradation (49)main-
tains cell adhesion by interacting with cell surface heparan sulfate chains of syndecan-4. Engagement of
syndecan-4 with TG-FN matrix complex initiates the cascade of signaling events leading to inside-out activa-
tion of integrins, focal adhesion formation, and actin cytoskeleton reorganization and the activation of survival
kinase pathway.
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Combinatory signaling from syndecans and integrins after
attachment to FN is essential for the appropriate organization
of the actin cytoskeleton and subsequent activation of the
MAPKs such as FAK (34, 41). Engagement of syndecan-4 with
FN-bound TG2 can form matrix attachments that generate
cross-talk between syndecans and integrins resulting in inte-
grin clustering through inside-out signaling. In support of this
model, our data showed that RGD-independent cell adhesion
to FN-bound TG2 promotes 1 integrin accumulation in focal
structures (data not shown) and phosphorylation of FAK at
Tyr397 and at Tyr861, which occurs in the event of ligand-inde-
pendent integrin clustering (40).Once activated, FAK can stim-
ulate ERK, which is linked to survival signaling. Given that the
TG-FN complex can rescue primary dermal fibroblasts from
anoikis with the maintenance of cell viability (19), it is not sur-
prising that the phosphorylation levels of the survival kinase
ERK1/2 were induced almost back to normal levels, and inhibi-
tion of ERK1/2 abolished RGD-independent cell adhesion in
response to TG-FN (data not shown).
An increasing number of reports now confirm the impor-
tance of TG2 in tissue injury and wound repair (44–46). RGD-
independent cell adhesion mediated by matrix-bound TG2-
syndecan-4 interactions could be physiologically relevant in
tissue remodeling during differentiation and/or after wounding
(7, 47). Both these events are known to cause up-regulation and
secretion of TG2 (44, 48) and involve remodeling of the matrix
by numerous proteases. This in turn leads to the subsequent
generation of soluble RGD-containing peptides (20), which
have the potential to compete and disrupt cell/matrix binding
sites leading to loss of cell adhesion and anoikis. Important to
our hypothesis is the observation that interaction of TG with
either FN or heparin leads to the increased resistance of TG2 to
proteolysis (49, 50). Therefore, in situations of matrix break-
down during tissue remodeling, a protease-resistant complex
rich in FN-bound TG2 could interact with syndecan-4 to rein-
force or substitute for RGD-dependent cell adhesion, thus fur-
ther extending the role of this multifunctional enzyme in tissue
repair. In conclusion, our results shown in this paper allow us to
propose a novel RGD-independent cell adhesion and cell sur-
vival process in which binding of syndecan-4 to FN-boundTG2
activates PKC, facilitating its association with 1 integrins,
leading to reinforcement of actin-stress fiber formation and
MAPK pathway activation (Fig. 6).
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